Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers
Clinical trial NCT03122548 · TERMINATED
Trial details
- NCT number
- NCT03122548
- Sponsor
- Aduro Biotech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2017-12-27
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.